Peniel M. Gumedzoe

Array ( [id] => 4240479 [patent_doc_number] => 06080788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Composition for improvement of cellular nutrition and mitochondrial energetics' [patent_app_type] => 1 [patent_app_number] => 9/002765 [patent_app_country] => US [patent_app_date] => 1998-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 8544 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080788.pdf [firstpage_image] =>[orig_patent_app_number] => 002765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220534 [patent_doc_number] => 06040326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => '3-deoxyglucosone production inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/997872 [patent_app_country] => US [patent_app_date] => 1997-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4365 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040326.pdf [firstpage_image] =>[orig_patent_app_number] => 997872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048694 [patent_doc_number] => 05968925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Process for continuous sintering of granules' [patent_app_type] => 1 [patent_app_number] => 8/983598 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1433 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968925.pdf [firstpage_image] =>[orig_patent_app_number] => 983598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3906644 [patent_doc_number] => 05898033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-27 [patent_title] => 'Antigen-processing cell-targeted conjugates' [patent_app_type] => 1 [patent_app_number] => 8/994334 [patent_app_country] => US [patent_app_date] => 1997-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4099 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/898/05898033.pdf [firstpage_image] =>[orig_patent_app_number] => 994334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933901 [patent_doc_number] => 05929058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Treatment agents and methods for treating type II diabetes and symptoms of type II diabetes' [patent_app_type] => 1 [patent_app_number] => 8/995739 [patent_app_country] => US [patent_app_date] => 1997-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4854 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929058.pdf [firstpage_image] =>[orig_patent_app_number] => 995739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3997247 [patent_doc_number] => 05919976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Sulfonated aliphatic compounds' [patent_app_type] => 1 [patent_app_number] => 8/986702 [patent_app_country] => US [patent_app_date] => 1997-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1581 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919976.pdf [firstpage_image] =>[orig_patent_app_number] => 986702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995766 [patent_doc_number] => 05985855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Treatment of global and focal ischemia using NAALADase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/974975 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14290 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985855.pdf [firstpage_image] =>[orig_patent_app_number] => 974975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995143 [patent_doc_number] => 05892045 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => '4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators' [patent_app_type] => 1 [patent_app_number] => 8/972280 [patent_app_country] => US [patent_app_date] => 1997-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7074 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892045.pdf [firstpage_image] =>[orig_patent_app_number] => 972280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4119192 [patent_doc_number] => 06071942 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Elevation of circulating blood histamine levels' [patent_app_type] => 1 [patent_app_number] => 8/969384 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10374 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071942.pdf [firstpage_image] =>[orig_patent_app_number] => 969384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082463 [patent_doc_number] => 06054462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Intranasal antimigraine compositions' [patent_app_type] => 1 [patent_app_number] => 8/963432 [patent_app_country] => US [patent_app_date] => 1997-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2799 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054462.pdf [firstpage_image] =>[orig_patent_app_number] => 963432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949966 [patent_doc_number] => 05955462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Anti-neurogenic inflammatory compounds and compositions and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/961475 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9928 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955462.pdf [firstpage_image] =>[orig_patent_app_number] => 961475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004541 [patent_doc_number] => 06004951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual' [patent_app_type] => 1 [patent_app_number] => 8/956175 [patent_app_country] => US [patent_app_date] => 1997-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7350 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004951.pdf [firstpage_image] =>[orig_patent_app_number] => 956175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4132350 [patent_doc_number] => 06034102 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Atherosclerosis treatment' [patent_app_type] => 1 [patent_app_number] => 8/955312 [patent_app_country] => US [patent_app_date] => 1997-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5848 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034102.pdf [firstpage_image] =>[orig_patent_app_number] => 955312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940562 [patent_doc_number] => 05981555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Compositions, kits and methods for administration of antilipemic drugs' [patent_app_type] => 1 [patent_app_number] => 8/937669 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 14875 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981555.pdf [firstpage_image] =>[orig_patent_app_number] => 937669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975891 [patent_doc_number] => 05916906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin B6' [patent_app_type] => 1 [patent_app_number] => 8/930234 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16006 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916906.pdf [firstpage_image] =>[orig_patent_app_number] => 930234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946742 [patent_doc_number] => 05998428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Compounds and methods for treating PDE IV-related diseases' [patent_app_type] => 1 [patent_app_number] => 8/944044 [patent_app_country] => US [patent_app_date] => 1997-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7294 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998428.pdf [firstpage_image] =>[orig_patent_app_number] => 944044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924169 [patent_doc_number] => 05914337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Compounds and pharmaceutical compositions thereof for eliciting analgesic effects' [patent_app_type] => 1 [patent_app_number] => 8/908440 [patent_app_country] => US [patent_app_date] => 1997-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3975 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914337.pdf [firstpage_image] =>[orig_patent_app_number] => 908440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945941 [patent_doc_number] => 05977090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/899319 [patent_app_country] => US [patent_app_date] => 1997-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26929 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977090.pdf [firstpage_image] =>[orig_patent_app_number] => 899319 [rel_patent_id] =>[rel_patent_doc_number] =>)